2026 NPPES data Gynecology Physician NPI 1316916224 MD
Verify on CMS →

KARIN DENEVI, MD

Gynecology Physician in DANVILLE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 131 beneficiaries · Gynecology Physician avg: 295
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

KARIN DENEVI, MD filed 1,172 Medicare Part D claims in 2023 as a Gynecology Physician in DANVILLE, California, prescribing 84% generic.

1K
Part D claims, 2023
84%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KARIN DENEVI, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,172 Top 23% higher than 77% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

KARIN DENEVI, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KARIN DENEVI, MD?

Quality data not reported

NPI registry status

Active

Issued 03/14/2006

NPI 1316916224

Primary specialty

Gynecology Physician

Niche

3,902 US NPIs in this specialty

Medicare Part D claims

1,172 297% vs specialty avg

2023 prescription claims

Specialty avg: 295

Specialty distribution in California

How Gynecology Physician compares to other specialties among California providers

California providers

Gynecology Physician share within California

1. Gynecology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Gynecology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Gynecology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Gynecology Physician ABMS/AOA estimate

Est. board-certified rate (Gynecology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Gynecology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KARIN DENEVI, MD is a Gynecology Physician provider practicing in DANVILLE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1316916224. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KARIN DENEVI, MD appears in the CMS NPPES registry as a Gynecology Physician provider holding MD credentials at 901 SAN RAMON VALLEY BLVD, DANVILLE, CA, 94526, with a listed phone of (925) 820-6456. NPI 1316916224 was issued on 03/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DENEVI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,172 prescription claims written by this provider, covering 131 Medicare beneficiaries and totaling roughly $76K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Gynecology Physician is a narrow specialty nationwide, with 3,902 enrolled providers across 53 states and an average of 295 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

901 SAN RAMON VALLEY BLVD
DANVILLE, CA 94526

Provider Details

NPI 1316916224
Specialty Gynecology Physician
Credentials MD
Gender Female
NPI Issued 03/14/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to KARIN DENEVI, MD. To verify KARIN DENEVI, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

KARIN DENEVI, MD — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 1,172 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,172
Total Claims
$76K
Total Drug Cost
131
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,223
Total Day Supply
62,034
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$33K
Generic Drug Cost
$42K
Antibiotic Claims
101

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
0.62

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
90
Estradiol
55
Synthroid
Levothyroxine Sodium
55
Dotti
Estradiol
43
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
41
Lisinopril
35
Rosuvastatin Calcium
34
Alprazolam
30
Atorvastatin Calcium
30
Escitalopram Oxalate
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Gynecology Physician Overview

How KARIN DENEVI, MD fits within the Gynecology Physician landscape nationally.

3,902
Gynecology Physician Providers in US
53
States with Gynecology Physician
295
Avg Claims per Provider

KARIN DENEVI, MD's 1,172 claims are above the specialty average of 295.

Nearby Gynecology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as DENEVI.

Compare Gynecology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KARIN DENEVI, MD's specialty?
KARIN DENEVI, MD specializes in Gynecology Physician and practices in DANVILLE, California. Credentials: MD.
How much does KARIN DENEVI, MD prescribe under Medicare Part D?
In 2023, KARIN DENEVI, MD wrote 1,172 Medicare Part D claims totaling $76K in drug costs for 131 beneficiaries.
Where is KARIN DENEVI, MD located?
KARIN DENEVI, MD is located at 901 SAN RAMON VALLEY BLVD, DANVILLE, CA, 94526. Phone: (925) 820-6456.
What is KARIN DENEVI, MD's NPI number?
KARIN DENEVI, MD's National Provider Identifier (NPI) is 1316916224, issued on 03/14/2006.
Does KARIN DENEVI, MD prescribe more brand-name or generic drugs?
KARIN DENEVI, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $33K in brand drug costs.
How many Gynecology Physician providers are there in the US?
There are 3,902 Gynecology Physician providers across 53 states in the US. The average Gynecology Physician provider writes 295 Medicare Part D claims per year.
What drugs does KARIN DENEVI, MD prescribe most often?
Based on 2023 Medicare Part D data, KARIN DENEVI, MD's most frequently prescribed drugs include Levothyroxine Sodium, Estradiol, Synthroid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KARIN DENEVI, MD accept Medicare?
KARIN DENEVI, MD appears in CMS Medicare data with 1,172 Part D claims and 131 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KARIN DENEVI, MD's credentials?
KARIN DENEVI, MD's NPI is 1316916224 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology